Alzheimer's disease is the most common form of dementia, causing progressive cell loss in the brain and affecting memory, thinking skills, and daily activities. While its exact cause is not fully understood, age, genetic predisposition, and certain lifestyle factors are thought to influence risk.
These findings come from one trial and need to be confirmed by independent research groups in larger patient populations.
This research does not establish that EECP treats, improves, or halts the progression of Alzheimer's disease.
EECP is not an approved or standard treatment method for Alzheimer's disease.
Protecting your cardiovascular health, as part of your overall circulatory system, may indirectly support cognitive health as well. If you have concerns about Alzheimer's disease, it is important to consult a neurologist for proper evaluation and care — people diagnosed with Alzheimer's disease, or with symptoms suggestive of it, should be evaluated by a neurologist.
Note: This content is for general informational purposes only and is not a substitute for medical advice. It does not imply that EECP is an approved, standard treatment for Alzheimer's disease, nor that it halts its progression or improves the disease.
Source: Juni JE, Burns JM, Salat DH, Hill D, Tally S, Martin JS, Devous MD, Moriarty PM. "Treatment of Clinically Diagnosed Alzheimer's Disease by External Counterpulsation: A Randomized Clinical Trial." American Journal of Alzheimer's Disease & Other Dementias, 2026. DOI: 10.1177/15333175261451918.